Offerings Archives - Page 27 of 166

2 minute read

Why Is Complement-Mediated Focused Annexon Stock Trading Higher Today?

December 21, 12:07 PM

On Wednesday, Annexon Inc (NASDAQ: ANNX) reported results from the Phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) healthy volunteer study of ANX1502 that targets the active form of C1s responsible for propagating classical pathway

ANNX

1 minute read

Why Is Immunotherapy-Focused Hookipa Pharma Stock Soaring Today?

By Vandana Singh

December 21, 12:02 PM

Gilead Sciences Inc (NASDAQ: GILD) announced on Thursday that it has purchased 15 million shares of HOOKIPA Pharma Inc (NASDAQ: HOOK) for approximately $21.25 million,

GILD

1 minute read

UPDATE: Longeveron Announces $2.36M Registered Direct Offering of 1.36M Shares at $1.745/Share

By Benzinga Newsdesk

December 21, 11:37 AM

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart

LGVN

2 minute read

Guardant Health Announces $90.7M Registered Direct Offering With Baillie Gifford Of 3,387,446 Shares Of Its Common Stock At An Offering Price Of $26.77 Per Share

By Benzinga Newsdesk

December 21, 10:07 AM

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, today announced that it has entered into a common stock purchase agreement with Baillie Gifford on behalf of accounts that it manages for the sale

1 minute read

Longeveron Announces Registered Direct Offering of 1.36M Shares at $1.62/Share

By Benzinga Newsdesk

December 21, 9:05 AM

Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as

LGVN

1 minute read

Shattuck Labs Announces $50M Public Offering Of Common Stock And Concurrent Private Placement Of Pre-Funded Warrants

By Benzinga Newsdesk

December 21, 9:03 AM

Shattuck Labs, Inc. ("Shattuck" or the "company") (NASDAQ:STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of

STTK

2 minute read

Tonix Pharmaceuticals Announces Registered Direct Offering Of Up To $144M; $30M Financing Upfront With Up To An Additional $114M Tied To The Exercise Of Warrants

By Benzinga Newsdesk

December 20, 11:36 AM

Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of warrants.CHATHAM, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) --

TNXP

1 minute read

Why Bluebird Bio Shares Are Getting Crushed Wednesday

By Adam Eckert

December 20, 10:26 AM

Bluebird Bio Inc (NASDAQ: BLUE) shares are tanking Wednesday after the company announced the pricing of a $125 million public offering of common stock<

BLUE

1 minute read

LQR House Cancels Representative Warrants To Bolster Shareholder Confidence; Committing To A Hiatus On Offerings And Capital Raises, Redirecting Efforts On Expanding E-Commerce Presence And Cultivating Marketing Partnerships

By Benzinga Newsdesk

December 20, 9:54 AM

With approximately $8 million in cash reserves, LQR House believes that the Company can preserve cash flow, sustain business growth, and prioritize profitability.On December 16, 2023, LQR House and designees of EF Hutton

LQR

1 minute read

KULR Announces Pricing Of $900,000 Public Offering Of 4.5M Shares Of Common Stock At A Price Of $0.20/Share

By Benzinga Newsdesk

December 20, 9:05 AM

KULR Technology Group, Inc. (NYSE:KULR) (the "Company" or "KULR"), a global leader in sustainable energy management, today announced it has priced its underwritten public offering (the "Offering") of 4,500,000 shares of

KULR